Immunotherapy Institute Helps Canadian Colon Cancer Patient Turns to Mexico After Healthcare System Fails Her PressReach · Jun 18, 2025
Nob Hill Therapeutics Expands Strategic Advisory Board with Two Distinguished Leaders in Respiratory Drug Development and Pulmonary Medicine PressReach · Jun 18, 2025
Embla Medical Recognized for Leadership in Accessibility and International Reach PressReach · Jun 18, 2025
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds PressReach · Jun 18, 2025
FreshRealm Voluntarily Recalls Chicken Fettuccine Alfredo Meals Due to Possible Listeria Contamination PressReach · Jun 18, 2025
Foresee Pharmaceuticals announces reaching a significant milestone, of complete enrollment of its Phase 3 Casppian trial for patients with Central Precocious Puberty (CPP) PressReach · Jun 17, 2025
The Center Origin Conducts Colorado's First Regulated High-Dose Psilocybin Session PressReach · Jun 17, 2025
SEEKING DOGS WITH EXTREME FEAR OF THUNDERSTORMS FOR VETERINARY STUDY IN FLORIDA PressReach · Jun 17, 2025
Exobiosphere and Space Cargo Unlimited Unite for High-Throughput Biotech in Space PressReach · Jun 17, 2025
